Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaomeng Wang

Showing results (41-50 of 480) with videos related to

Pageof 48
Sort By:
Journal of Medicinal Chemistry|March 4, 2005
CHMIS-C: a comprehensive herbal medicine information system for cancerXueliang Fang, Lei Shao, Hui Zhang, et al.
Journal of Medicinal Chemistry|May 28, 2004
The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structuresRenxiao Wang, Xueliang Fang, Yipin Lu, et al.
Applied Optics|June 10, 2024
General spatial photonic Ising machine based on the interaction matrix eigendecomposition methodShaomeng Wang, Wenjia Zhang, Xin Ye, et al.
Drug Discovery Today. Technologies|October 23, 2016
Role of BET proteins in castration-resistant prostate cancerEster Fernandez-Salas, Shaomeng Wang, Arul M Chinnaiyan
Journal of Chemical Information and Computer Sciences|January 27, 2004
Web-based tools for mining the NCI databases for anticancer drug discoveryXueliang Fang, Lei Shao, Hui Zhang, et al.
Journal of Chemical Information and Computer Sciences|November 24, 2004
An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexesRenxiao Wang, Yipin Lu, Xueliang Fang, et al.
Journal of Medicinal Chemistry|April 17, 2019
Drug Metabolism and Toxicology Special Issue Call for PapersF Peter Guengerich, Gunda I Georg, Shaomeng Wang
Future Microbiology|June 1, 2018
Global transcriptional regulation by BirA in enterohemorrhagic Escherichia coli O157:H7Bin Yang, Lingyan Jiang, Shaomeng Wang, et al.
Journal of Medicinal Chemistry|November 15, 2014
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatmentYujun Zhao, Angelo Aguilar, Denzil Bernard, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubilityJianyong Chen, Ke Ding, Beth Levant, et al.
Pageof 48

Showing results (41-50 of 480) with videos related to

Sort By:
Pageof 48
Journal of Medicinal Chemistry|March 4, 2005
CHMIS-C: a comprehensive herbal medicine information system for cancerXueliang Fang, Lei Shao, Hui Zhang, et al.
Journal of Medicinal Chemistry|May 28, 2004
The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structuresRenxiao Wang, Xueliang Fang, Yipin Lu, et al.
Applied Optics|June 10, 2024
General spatial photonic Ising machine based on the interaction matrix eigendecomposition methodShaomeng Wang, Wenjia Zhang, Xin Ye, et al.
Drug Discovery Today. Technologies|October 23, 2016
Role of BET proteins in castration-resistant prostate cancerEster Fernandez-Salas, Shaomeng Wang, Arul M Chinnaiyan
Journal of Chemical Information and Computer Sciences|January 27, 2004
Web-based tools for mining the NCI databases for anticancer drug discoveryXueliang Fang, Lei Shao, Hui Zhang, et al.
Journal of Chemical Information and Computer Sciences|November 24, 2004
An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexesRenxiao Wang, Yipin Lu, Xueliang Fang, et al.
Journal of Medicinal Chemistry|April 17, 2019
Drug Metabolism and Toxicology Special Issue Call for PapersF Peter Guengerich, Gunda I Georg, Shaomeng Wang
Future Microbiology|June 1, 2018
Global transcriptional regulation by BirA in enterohemorrhagic Escherichia coli O157:H7Bin Yang, Lingyan Jiang, Shaomeng Wang, et al.
Journal of Medicinal Chemistry|November 15, 2014
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatmentYujun Zhao, Angelo Aguilar, Denzil Bernard, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubilityJianyong Chen, Ke Ding, Beth Levant, et al.
Pageof 48